CLINICAL_TRIALS ClinicalTrials.gov record update

Trans-Arterial Chemo-Embolization (TACE) vs TACE Plus Stereotactic Body Radio Therapy (SBRT) in the Treatment of Hepatocellular Carcinoma (HCC)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT02070419
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:35:48.368210+00:00
Published At: 2014-12-02T00:00:00+00:00
Record Updated At: 2014-12-02
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Adult Primary Hepatocellular Carcinoma", "Recurrent Adult Primary Liver Cancer", "Stage I Adult Primary Liver Cancer", "Stage II Adult Primary Liver Cancer", "Stage IIIA Adult Primary Liver Cancer"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2014-12-02"
protocolSection.identificationModule.nctId: "NCT02070419"
protocolSection.identificationModule.officialTitle: "Trans-Arterial Chemo-Embolization (TACE) vs TACE Plus Stereotactic Body Radio Therapy (SBRT) in the Treatment of Hepatocellular Carcinoma (HCC)"
protocolSection.statusModule.overallStatus: "WITHDRAWN"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.